Multicancer Detection Using Whole-Body MRI in a Preventive Health Population: A Retrospective Observational Study of 1,011 Individuals
Background: Single-cancer screening (SCS) reduces mortality for select cancers but overlooks many malignancies that contribute to overall cancer deaths. Screening whole-body MRI (sWB-MRI) is an emerging modality for multi-cancer detection (MCD) with potential in preventive care. We assessed the diagnostic yield and clinical implications of sWB-MRI in a preventive health population. Methods: In this retrospective single-center study, we evaluated 1,011 individuals without known active cancer who underwent noncontrast, multiparametric sWB-MRI (1.5 T with diffusion-weighted imaging) from January to December 2022. Of 2,632 individuals scanned, 1,044 (39.7%) completed routine clinical follow-up telephone calls approximately 12-16 months later; 33 with known active cancer were excluded. Imaging spanned head-to-ankle anatomy for the vast majority of studies, with structured reports available for primary care physician review. The primary outcome was the observed cancer detection percentage (CDP), based on patient-reported histopathological diagnoses of malignancy following evaluation or management of findings initially identified on sWB-MRI, along with the distribution of cancer types relative to established screening categories. Results: The cohort consisted of 52% males, with a mean age of 56.4 ± 12.9 years. Tissue sampling was reported in 4.9% (n = 50), with diagnostic-intent tissue sampling (dTS) in 4.1% (n = 41). The overall cancer detection percentage (O-CDP) was 2.18% (95% CI: 1.37%-3.28%), with 3.0% observed among those aged 65-79 years. Of 22 detected cancers, 15 (68.2%) belonged to cancer types outside the five predefined SCS categories, and one (4.5%) was of unknown primary origin. Fourteen cancers (63.6%) were retrospectively estimated to have localized disease. Two additional interval breast cancer diagnoses (0.2%) were reported during follow-up but were not identified in the original sWB-MRI reports. Clinically significant noncancer findings (e.g., aneurysms, meningiomas, hepatosteatosis) were associated with reported subsequent clinical interventions or monitoring. Conclusions: In this population, sWB-MRI enabled broad detection of some cancers not typically identified by SCS. The findings highlight the need to explore MCD imaging in larger, risk-stratified cohorts to inform screening policy, address missed cancer burdens, and enhance early detection strategies in population health. Prospective studies with standardized reporting frameworks (ONCO-RADS) and long-term outcomes are needed to support broader clinical integration.
Authors
- Jeffrey Michael Venstrom
- Alex Exuzides (ORCID: https://orcid.org/0000-0001-9971-9485)
- Candace Westgate (ORCID: https://orcid.org/0009-0009-5137-9552)
- Madhurima Datta (ORCID: https://orcid.org/0000-0003-1781-3377)
- Rebecca Nayeri
- Daniel J. Durand (ORCID: https://orcid.org/0000-0001-7290-3135)
- Pratik Shingru (ORCID: https://orcid.org/0009-0007-3039-9461)
- Sam Hashemi (ORCID: https://orcid.org/0009-0003-0640-6466)
- Yosef G. Chodakiewitz (ORCID: https://orcid.org/0000-0002-0268-1060)
- Saqib Basar (ORCID: https://orcid.org/0000-0002-8596-1040)
Institutions
- Community Health Network (US)
- St. Helena Hospital (US)
- VA Greater Los Angeles Healthcare System (US)
Publication Details
- Journal
- Cureus
- Published
- 2026-11-18
- DOI
- https://doi.org/10.7759/cureus.119908
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00